For diabetics, here’s another ‘cure’ that’s worse than the disease

Just this week I warned you about a terrifying new push to use gastric bypass surgery to shrink diabetics’ stomachs down to the size of an egg.

And I called it the most dangerous treatment plan ever aimed at people with diabetes.

But just leave it to Big Pharma to try to prove me wrong.

Because it looks like there is a new plan in the works to use a chemotherapy drug – one designed for rare blood cancers — to help you manage your blood sugar.

It’s being called a “new hope” for people with diabetes – even though it could damage your heart and even cause uncontrollable bleeding.

And the worst part? There’s absolutely nothing keeping the mainstream from pushing it on you or someone you love right now.

A new use for a ‘last resort’
Call me crazy – but most people I know do everything they can to stay off of cancer drugs.

But with so many people developing diabetes these days – and with so much money to be made – it looks like Big Pharma is throwing caution to the wind.

And that could mean big trouble for you or someone you love.

Researchers from the Scripps Research Institute in California and a South Korean drug company have been testing the chemo drug Gleevec on mice, and they’re claiming it has an amazing ability to stabilize blood sugar.

And if you’re thinking that popping cancer meds doesn’t sound like the smartest way to beat diabetes, well, join the club.

You see, researchers are claiming that Gleevec works in a similar way as a class of diabetes drugs called TZDs (short for thiazolidinediones).

And that should make you feel about as comfortable as sharing a sleeping bag with a rattlesnake. These are the same TZD meds that have been restricted and banned around the world for causing serious side effects like heart failure and bladder cancer – and even killing people!

And these researchers haven’t found a better mousetrap with Gleevec – just a new way to make us guinea pigs.

You see, Gleevec was first approved by the FDA 15 years ago to treat a very rare and deadly type of blood cancer. It’s a drug of last resort when there are very few treatment options.

And there’s a very good reason Gleevec isn’t more widely used. Just some of the complications linked to the drug include:

  • Severe fluid retention,
  • Anemia,
  • Congestive heart failure,
  • Liver damage,
  • Intestinal perforations that can be fatal, and
  • Sudden hemorrhaging.

And believe it or not, that’s the short list! Leave it to Big Pharma to come up with a treatment that makes diabetes look good by comparison.

Like I said, there’s actually nothing that’s stopping doctors from pushing Gleevec on diabetics right now. That’s because, under FDA rules, docs can prescribe it “off label” for just about anything they want.

But make no mistake about it – this is a drug that doesn’t deserve a place in your medicine cabinet, especially for a condition as common as diabetes.

As I’ve told you before, there are lots of natural options for treating diabetes – including berberine, which has gone toe-to-toe with powerful diabetes meds in major studies.

If you or someone you care about has diabetes, you have options. But taking something as potentially dangerous as Gleevec, no matter how well it worked on mice, shouldn’t be one of them.
“Cancer drug Gleevec holds promise for type 2 diabetes” Stephen Feller, March 28, 2016, UPI,